- Home
- BGM vs PMN Comparison
BGM vs PMN Comparison
Compare BGM & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGM
- PMN
- Stock Information
- Founded
- BGM 2019
- PMN 2004
- Country
- BGM China
- PMN Canada
- Employees
- BGM N/A
- PMN N/A
- Industry
- BGM
- PMN Pharmaceuticals and Biotechnology
- Sector
- BGM
- PMN Health Care
- Exchange
- BGM NYSE
- PMN Nasdaq
- Market Cap
- BGM 45.5M
- PMN 37.4M
- IPO Year
- BGM 2021
- PMN N/A
- Fundamental
- Price
- BGM $8.16
- PMN $1.30
- Analyst Decision
- BGM
- PMN Strong Buy
- Analyst Count
- BGM 0
- PMN 1
- Target Price
- BGM N/A
- PMN $8.00
- AVG Volume (30 Days)
- BGM 31.3K
- PMN 54.8K
- Earning Date
- BGM 08-14-2024
- PMN 11-12-2024
- Dividend Yield
- BGM N/A
- PMN N/A
- EPS Growth
- BGM N/A
- PMN N/A
- EPS
- BGM N/A
- PMN N/A
- Revenue
- BGM $29,870,461.00
- PMN N/A
- Revenue This Year
- BGM N/A
- PMN N/A
- Revenue Next Year
- BGM N/A
- PMN N/A
- P/E Ratio
- BGM N/A
- PMN N/A
- Revenue Growth
- BGM N/A
- PMN N/A
- 52 Week Low
- BGM $1.78
- PMN $0.95
- 52 Week High
- BGM $8.96
- PMN $3.10
- Technical
- Relative Strength Index (RSI)
- BGM N/A
- PMN 50.21
- Support Level
- BGM N/A
- PMN $1.23
- Resistance Level
- BGM N/A
- PMN $1.40
- Average True Range (ATR)
- BGM 0.00
- PMN 0.13
- MACD
- BGM 0.00
- PMN 0.02
- Stochastic Oscillator
- BGM 0.00
- PMN 72.73
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.